E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)

NCT00832819 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small-cell Lung Cancer

Interventions

DRUG: E7080
DRUG: E7080
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Eisai Co., Ltd.